Co-Authors
This is a "connection" page, showing publications co-authored by Fuxiang Wang and Yingxia Liu.
Connection Strength
1.619
-
Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression. Front Immunol. 2021; 12:691879.
Score: 0.237
-
Laboratory Diagnosis and Monitoring the Viral Shedding of SARS-CoV-2 Infection. Innovation (N Y). 2020 11 25; 1(3):100061.
Score: 0.228
-
Predicting Illness Severity and Short-Term Outcomes of COVID-19: A Retrospective Cohort Study in China. Innovation (N Y). 2020 May 21; 1(1):100007.
Score: 0.221
-
The novel coronavirus (COVID-19) pneumonia with negative detection of viral ribonucleic acid from nasopharyngeal swabs: a case report. BMC Infect Dis. 2020 Apr 30; 20(1):317.
Score: 0.220
-
Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19. J Allergy Clin Immunol. 2020 Jul; 146(1):119-127.e4.
Score: 0.220
-
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020 03; 63(3):364-374.
Score: 0.217
-
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis. 2020 11 19; 71(16):2027-2034.
Score: 0.057
-
Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis. 2020 06; 26(6):1320-1323.
Score: 0.055
-
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 04 28; 323(16):1582-1589.
Score: 0.055
-
First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection. 2020 Oct; 48(5):773-777.
Score: 0.055
-
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering (Beijing). 2020 Oct; 6(10):1192-1198.
Score: 0.055